Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases. Adv Ther. 2024 Feb; 41(2):509-533.
View in:
PubMed
subject areas
Adalimumab
Arthritis, Rheumatoid
Biosimilar Pharmaceuticals
Crohn Disease
Humans
Treatment Outcome
Tumor Necrosis Factor-alpha
authors with profiles
Stephen B. Hanauer